Abemaciclib: The Treatment My Cancer Patients Needed

Dear Dr. Renukaprasad A R, Are you aware of the clinical efficacy and safety of abemaciclib in hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (MBC) patients with poor prognostic factors? Let's get glued up to this exclusive webinar from Eli Lilly with Dr. Anwar Al Nouri, Dr. Ashish Singh, Dr. Krupa Shankar, Dr. Anita Ramesh, Dr. Arun Ramanan, and Dr. Suman Kalyan as they share their real-life clinical experiences about the effects of abemaciclib in MBC patients and how its use culminates in improved patient outcomes, even those with poor prognosis. Join us TODAY at 08:00 PM IST. The experts will address your queries live in the Q&A session. Looking forward to your active participation! Session highlights: Exploring response in MBC patients as a first-line setting - Dr. Anwar Al Nouri Clinical case presentation I - Dr. Anwar Al Nouri Clinical case presentation II - Dr. Krupa Shankar Clinical case presentation III - Dr. Ashish Singh Clinical case presentation IV - Dr. Arun Ramanan Q&A with the experts: Fine-tune the treatment for advanced MBC patients with poor prognoses Click to Join   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*